Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -33.49 | 15.83 |
| PEG Ratio (TTM) | 0.06 | -0.59 |
| P/S Ratio (TTM) | 0.02 | 1.82 |
| P/B Ratio (TTM) | 0.64 | 2.10 |
| P/FCF Ratio (TTM) | 0.19 | 10.06 |
| Price to 5YR AVG Earnings Ratio | N/A | 23.56 |
| Price to 5YR AVG FCF Ratio | N/A | -29.07 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.09% | 2.73% |
| ROE (TTM) | -1.90% | 7.58% |
| Net Profit Margin (TTM) | -3.94% | -2.56% |
| ROIC 5YR AVG | N/A | 7.64% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| Cash Flow | N/A | N/A | N/A |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 0.83 |
| Quick Ratio (TTM) | N/A | 0.77 |
| D/E Ratio (TTM) | 1.01 | 1.50 |
| Interest Coverage (TTM) | 0.28 | 5.42 |
| Piotroski F-Score | N/A | 7 |
| Altman Z-Score | 3.00 | 1.04 |
| LTL to 5YR AVG FCF | N/A | -8.61 |
| Shares Outstanding Growth 5YR AVG | N/A | 30.72% |